The Advisory Committee on Immunization Practices voted against requiring a prescription for the COVID-19 vaccine. (Photo by Nathan Posner/Anadolu Agency via Getty Images)
Anadolu Agency via Getty Images
A highly awaited gathering of the CDC’s Advisory Committee on Immunization Practices (ACIP) took place this past Thursday and Friday, leading to significant policy decisions regarding vaccination protocols. The committee’s notable decision was to not mandate a prescription for COVID-19 vaccinations. Additionally, they voted to exclude the measles, mumps, rubella, and varicella (MMRV) vaccine from the list of approved childhood vaccinations.
COVID-19 Vaccine Recommendations
A central focus of the meeting was on the guidelines surrounding COVID-19 vaccinations. The committee reached a consensus that vaccination should involve “individual-based decision-making,” especially advising that individuals aged between 6 months to 64 years should evaluate the risk-benefit ratio, particularly those at a higher risk for severe illness.
A vigorous discussion arose around the idea of requiring prescriptions for COVID-19 vaccinations. The motion presented posited, “It is the sense of the committee that state and local jurisdictions should require a prescription for the administration of a COVID-19 vaccination.”
Dr. Cody Meissner from the Geisel School of Medicine at Dartmouth expressed strong opposition to mandating prescriptions, noting that such a requirement could hinder access to the vaccine and disproportionately impact lower-income individuals, thereby perpetuating longstanding health inequities.
Advocates of the prescription requirement countered by citing potential risks associated with vaccinations and insisted that a licensed healthcare provider should conduct a risk-benefit analysis for patients before inoculation. The vote ended in a tie of six members in favor and six against requiring a prescription, with ACIP chair Dr. Martin Kulldorff breaking the deadlock by voting against it.
MMRV Vaccine Recommendations
In another major decision, the committee voted 8 to 3 to recommend that children under 4 years old not receive the MMRV vaccine, a combined immunization for measles, mumps, rubella, and chickenpox. This vaccine, approved in 2005, was developed to minimize the number of shots children must undergo, achieving high levels of effectiveness. However, it has been noted that the combination vaccine carries a slightly higher risk of febrile seizures compared to the individual vaccines.
Current guidelines suggest children receive either two doses of the MMRV vaccine or two doses each of the MMR and varicella vaccines. The majority of parents in the U.S.—about 85%—opt for the separate vaccinations, leaving only 15% choosing the combination option. Therefore, the implications of this new recommendation might be minimal.
Interestingly, in an earlier meeting, the panel supported maintaining coverage of the MMRV vaccine under the Vaccines for Children (VFC) program by a vote of 8 to 1. However, on the following day, the committee reversed this decision, voting to remove the MMRV vaccine from the VFC program list.
The Advisory Committee On Immunization Practices
Established in 1964 by the U.S. Surgeon General, the ACIP has continuously aimed to provide advice and guidance to the CDC’s director on the use of vaccines and related agents to effectively control vaccine-preventable diseases among the U.S. civilian population. When the CDC’s director accepts the committee’s recommendations, they are published as official vaccination guidelines by the CDC.
An essential part of the ACIP’s role is to recommend which vaccinations should be included in the Vaccines for Children Program, which was established by Congress in 1993 to make vaccinations free for eligible children. Since its inception, this initiative has significantly reduced access disparities based on socioeconomic status.
The committee’s credibility has faced scrutiny following a controversial reshuffling led by Health and Human Services Secretary Robert F. Kennedy Jr., who removed all 17 sitting members in June. Medical associations, including the American Academy of Family Physicians and the Infectious Diseases Society of America, expressed criticism, fearing that the newly appointed members might share Kennedy’s vaccine skepticism, thereby jeopardizing public trust in vaccination efforts. Recently, 12 new members have been appointed to the ACIP.
The recommendations made during this meeting will be forwarded to the current acting director of the CDC, Jim O’Neill, following the recent dismissal of Susan Monarez from the position.
